Skip to content

To study the effect of Matulunga Tail Karnapooran in Karnakandu w.s.r to Otomycosis

Open randomised controlled clinical study to evaluate the efficacy of Matulunga Tail Karnapooran in Karnakandu w.s.r. to Otomycosis. - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083836
Enrollment
80
Registered
2025-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H628- Other disorders of external ear indiseases classified elsewhere

Interventions

None listed

Sponsors

Dr Manjusha Manikrao Patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having sign and symptoms of Karnakandu and otomycosis unilateral or bilateral ear with Intact tympanic membrane

Exclusion criteria

Exclusion criteria: Patient other than Karnakandu with special reference to Otomycosis will be excluded as CSOM, ASOM, Perforation of tympanic membrane, Malignant otitis externa) Patient having k/c/o any systemic disease with complications which can lead to interference with the study

Design outcomes

Primary

MeasureTime frame
Reduced Itching in ear, Earache,Ear dischargeTimepoint: 15 days

Secondary

MeasureTime frame
Reduced Itching in ear, Earache, Ear discharge,Improved lifestyle & health of the Patient. To studya the adverse effect of ayurvedic formulation, if anyTimepoint: 30 days

Countries

India

Contacts

Public ContactDr Kiran Patil

Yashwant Ayurvedic Medical College PGT and RC Kodoli

dr.kp1976@gmail.com7020519271

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026